{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:14:38Z","timestamp":1792700078225,"version":"4.5.0"},"reference-count":227,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2018,11,24]]},"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:p>Gaucher disease (GD) results from a deficiency of glucocerebrosidase activity and the subsequent accumulation of the enzyme\u2019s metabolites, principally glucosylsphingosine and glucosylceramide. There are three principal forms: Type I, which is the most common, is usually considered non-neuronopathic. Type II, III and IIIc manifest earlier and have neurological sequelae due to markedly reduced enzyme activity. Gaucher\u2019s can be associated with ophthalmological sequelae but these have not been systematically reviewed. We therefore performed a comprehensive literature review of all such ophthalmic abnormalities associated with the different types of Gaucher disease. We systematically searched the literature (1950 \u2013 present) for functional and structural ocular abnormalities arising in patients with Gaucher disease and found that all subtypes can be associated with ophthalmic abnormalities; these range from recently described intraocular lesions to disease involving the adnexae, peripheral nerves and brain. In summary, Gaucher can affect most parts of the eye. Rarely is it sight-threatening; some but not all manifestations are amenable to treatment, including with enzyme replacement and substrate reduction therapy. Retinal involvement is rare but patients with ocular manifestations should be monitored and treated early to reduce the risk of progression and further complications. As Gaucher disease is also associated with Parkinsons disease and may also confer an increased risk of malignancy (particularly haematological forms and melanoma), any ocular abnormalities should be fully investigated to exclude these potential underlying conditions.<\/jats:p>","DOI":"10.1136\/bjophthalmol-2018-312846","type":"journal-article","created":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T22:15:14Z","timestamp":1546726514000},"page":"315-326","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":31,"title":["Ophthalmic manifestations of Gaucher disease: the most common lysosomal storage disorder"],"prefix":"10.1136","volume":"103","author":[{"given":"Aaron W","family":"Winter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis H","family":"Ospina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C P","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,1,5]]},"reference":[{"key":"2024100707200856000_103.3.315.1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.18.2835"},{"key":"2024100707200856000_103.3.315.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1982.tb07950.x"},{"key":"2024100707200856000_103.3.315.3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1023\/A:1012496514170","article-title":"Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses","volume":"24","author":"Cox","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"2024100707200856000_103.3.315.4","first-page":"72","article-title":"Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history","volume":"12","author":"Baris","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"key":"2024100707200856000_103.3.315.5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","article-title":"Neuronopathic gaucher disease: demographic and clinical features of 131 patients enrolled in the international collaborative gaucher group neurological outcomes subregistry","volume":"33","author":"Tylki-Szyma\u0144ska","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"2024100707200856000_103.3.315.6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/192761","article-title":"Pathogenesis of bone alterations in gaucher disease: the role of immune system","volume":"2015","author":"Mucci","year":"2015","journal-title":"J Immunol Res"},{"key":"2024100707200856000_103.3.315.7","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/bjh.12335","article-title":"Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature","volume":"161","author":"Arends","year":"2013","journal-title":"Br J Haematol"},{"key":"2024100707200856000_103.3.315.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2005.03.004"},{"key":"2024100707200856000_103.3.315.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2005.08.004"},{"key":"2024100707200856000_103.3.315.10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21362"},{"key":"2024100707200856000_103.3.315.11","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevOncog.2013006145"},{"key":"2024100707200856000_103.3.315.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2004.08.015"},{"key":"2024100707200856000_103.3.315.13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10038-007-0135-4","article-title":"Mutation analysis and genotype\/phenotype relationships of Gaucher disease patients in Spain","volume":"52","author":"Alfonso","year":"2007","journal-title":"J Hum Genet"},{"key":"2024100707200856000_103.3.315.14","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24945"},{"key":"2024100707200856000_103.3.315.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2013.04.012"},{"key":"2024100707200856000_103.3.315.16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamaneurol.2014.2950","article-title":"Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort","volume":"72","author":"Beavan","year":"2015","journal-title":"JAMA Neurol"},{"key":"2024100707200856000_103.3.315.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(97)80035-2"},{"key":"2024100707200856000_103.3.315.18","doi-asserted-by":"publisher","DOI":"10.1136\/fn.82.2.F163"},{"key":"2024100707200856000_103.3.315.19","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.43.10.1993","article-title":"Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher\"s disease","volume":"43","author":"Patterson","year":"1993","journal-title":"Neurology"},{"key":"2024100707200856000_103.3.315.20","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(95)91688-1","article-title":"Gaucher\"s disease variant characterised by progressive calcification of heart valves and unique genotype","volume":"346","author":"Abrahamov","year":"1995","journal-title":"The Lancet"},{"key":"2024100707200856000_103.3.315.21","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.32.9.740"},{"key":"2024100707200856000_103.3.315.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(97)80033-9"},{"key":"2024100707200856000_103.3.315.23","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.34.2.175","article-title":"D409H\/D409H genotype in Gaucher-like disease","volume":"34","author":"Uyama","year":"1997","journal-title":"J Med Genet"},{"key":"2024100707200856000_103.3.315.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2012.10.010"},{"key":"2024100707200856000_103.3.315.25","first-page":"e864","article-title":"How to conduct a systematic review: a narrative literature review","volume":"8","author":"Jahan","year":"2016","journal-title":"Cureus"},{"key":"2024100707200856000_103.3.315.26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022410","article-title":"The saccadic and neurological deficits in type 3 Gaucher disease","volume":"6","author":"Benko","year":"2011","journal-title":"PLoS One"},{"key":"2024100707200856000_103.3.315.27","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21491"},{"key":"2024100707200856000_103.3.315.28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaapos.2005.04.013","article-title":"Type 3 Gaucher\u2019s disease in a three-year-old child: saccadic eye movements Analysis","volume":"9","author":"Accardo","year":"2005","journal-title":"Journal of American Association for Pediatric Ophthalmology and Strabismus"},{"key":"2024100707200856000_103.3.315.29","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-973507"},{"key":"2024100707200856000_103.3.315.30","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.84.5.451"},{"key":"2024100707200856000_103.3.315.31","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.11.2070"},{"key":"2024100707200856000_103.3.315.32","doi-asserted-by":"publisher","DOI":"10.1007\/BF00441578"},{"key":"2024100707200856000_103.3.315.33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/WNO.0b013e3181ce2c98","article-title":"Bilateral pseudohypopyon as a presenting feature of recurrent diffuse large B-cell lymphoma","volume":"30","author":"Dorrepaal","year":"2010","journal-title":"J Neuroophthalmol"},{"key":"2024100707200856000_103.3.315.34","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM199805143382016","article-title":"Loss of vision in Gaucher\"s disease and its reversal by enzyme-replacement therapy","volume":"338","author":"vom Dahl","year":"1998","journal-title":"N Engl J Med Overseas Ed"},{"key":"2024100707200856000_103.3.315.35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-6-25"},{"key":"2024100707200856000_103.3.315.36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00417-011-1745-2","article-title":"A branch retinal artery occlusion in a patient with Gaucher disease","volume":"250","author":"Bruscolini","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2024100707200856000_103.3.315.37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-442467"},{"key":"2024100707200856000_103.3.315.38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cyto.b.20539","article-title":"A cytometric study of the red blood cells in Gaucher disease reveals their abnormal shape that may be involved in increased erythrophagocytosis","volume":"80B","author":"Bratosin","year":"2011","journal-title":"Cytometry B Clin Cytom"},{"key":"2024100707200856000_103.3.315.39","doi-asserted-by":"publisher","DOI":"10.3233\/CH-2008-1121"},{"key":"2024100707200856000_103.3.315.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2004.08.023"},{"key":"2024100707200856000_103.3.315.41","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/90.1.19"},{"key":"2024100707200856000_103.3.315.42","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ajo.2005.10.039","article-title":"Uveitis in Gaucher disease","volume":"141","author":"Roos","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"2024100707200856000_103.3.315.43","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4672"},{"key":"2024100707200856000_103.3.315.44","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.11.1189"},{"key":"2024100707200856000_103.3.315.45","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930701)72:1<219::AID-CNCR2820720139>3.0.CO;2-Y"},{"key":"2024100707200856000_103.3.315.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.12.081"},{"key":"2024100707200856000_103.3.315.47","doi-asserted-by":"publisher","DOI":"10.1002\/path.4227"},{"key":"2024100707200856000_103.3.315.48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/08880010590896288","article-title":"Non-Hodgkin lymphoma presenting with uveitis occurring after blunt trauma","volume":"22","author":"Soylu","year":"2005","journal-title":"Pediatr Hematol Oncol"},{"key":"2024100707200856000_103.3.315.49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0181-5512(05)81022-8","article-title":"MALT-type B-cell lymphoma masquerading as scleritis or posterior uveitis","volume":"28","author":"Gaucher","year":"2005","journal-title":"J Fr Ophtalmol"},{"key":"2024100707200856000_103.3.315.50","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10545-007-0610-2","article-title":"Parotid gland involvement, the presenting sign of high grade non-Hodgkin lymphoma in two patients with Gaucher disease and sicca syndrome","volume":"30","author":"Shvidel","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"2024100707200856000_103.3.315.51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0901281"},{"key":"2024100707200856000_103.3.315.52","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23774"},{"key":"2024100707200856000_103.3.315.53","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9298-4"},{"key":"2024100707200856000_103.3.315.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2006.02.004"},{"key":"2024100707200856000_103.3.315.55","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.024455"},{"key":"2024100707200856000_103.3.315.56","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/mds.23109","article-title":"Atypical parkinsonism with apraxia and supranuclear gaze abnormalities in type 1 Gaucher disease. Expanding the spectrum: case report and literature review","volume":"25","author":"Alonso-Canovas","year":"2010","journal-title":"Mov Disord"},{"key":"2024100707200856000_103.3.315.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.06.001"},{"key":"2024100707200856000_103.3.315.58","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2012.1.13"},{"key":"2024100707200856000_103.3.315.59","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.111518"},{"key":"2024100707200856000_103.3.315.60","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22593"},{"key":"2024100707200856000_103.3.315.61","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.106"},{"key":"2024100707200856000_103.3.315.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.05.003"},{"key":"2024100707200856000_103.3.315.63","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.4"},{"key":"2024100707200856000_103.3.315.64","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/WNO.0b013e3182701745","article-title":"Retinal nerve fiber layer thickness in parkinson disease","volume":"33","author":"Kirbas","year":"2013","journal-title":"J Neuroophthalmol"},{"key":"2024100707200856000_103.3.315.65","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-012-1125-7"},{"key":"2024100707200856000_103.3.315.66","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.50.7.414"},{"key":"2024100707200856000_103.3.315.67","first-page":"85","article-title":"Sandhoff disease: a prevalent form of infantile GM2 gangliosidosis in Lebanon","volume":"33","author":"Der Kaloustian","year":"1981","journal-title":"Am J Hum Genet"},{"key":"2024100707200856000_103.3.315.68","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0002-9394(14)75945-8","article-title":"Ocular manifestations of group a niemann-pick disease","volume":"85","author":"Walton","year":"1978","journal-title":"Am J Ophthalmol"},{"key":"2024100707200856000_103.3.315.69","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19990702)85:1<38::AID-AJMG8>3.0.CO;2-3"},{"key":"2024100707200856000_103.3.315.70","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3928\/0191-3913-19840701-04","article-title":"Ocular features of multiple sulfatase deficiency and a new variant of metachromatic leukodystrophy","volume":"21","author":"Bateman","year":"1984","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"2024100707200856000_103.3.315.71","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF01800078","article-title":"Cherry red spot in association with galactosylceramide-beta-galactosidase deficiency","volume":"10","author":"Hofman","year":"1987","journal-title":"J Inherit Metab Dis"},{"key":"2024100707200856000_103.3.315.72","doi-asserted-by":"publisher","DOI":"10.1067\/S0022-3476(03)00302-0"},{"key":"2024100707200856000_103.3.315.73","unstructured":"Wray S . Retinopathy associated with defects in metabolism. In: Duane T , ed. Clinical ophthalmology. Hagerstown Md: Harper & Row, 1978: 1\u201338."},{"key":"2024100707200856000_103.3.315.74","unstructured":"Walsh F , Hoyt W . Clinical neuro-ophthalmology. Baltimore: Williams & Wilkins Co, 1969: 813."},{"key":"2024100707200856000_103.3.315.75","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bcmd.2006.11.003","article-title":"Gaucher disease among Chinese patients: review on genotype\/phenotype correlation from 29 patients and identification of novel and rare alleles","volume":"38","author":"Choy","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"2024100707200856000_103.3.315.76","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2012.55.2.48"},{"key":"2024100707200856000_103.3.315.77","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(95)90097-7"},{"key":"2024100707200856000_103.3.315.78","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c6471","article-title":"Orphan drug pricing may warrant a competition law investigation","volume":"341","author":"Roos","year":"2010","journal-title":"BMJ"},{"key":"2024100707200856000_103.3.315.79","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-135"},{"key":"2024100707200856000_103.3.315.80","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcu016"},{"key":"2024100707200856000_103.3.315.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2015.09.002"},{"key":"2024100707200856000_103.3.315.82","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20444"},{"key":"2024100707200856000_103.3.315.83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0606016103"},{"key":"2024100707200856000_103.3.315.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2006.07.002"},{"key":"2024100707200856000_103.3.315.85","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1119181109"},{"key":"2024100707200856000_103.3.315.86","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.012393"},{"key":"2024100707200856000_103.3.315.87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2008.11.002"},{"key":"2024100707200856000_103.3.315.88","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1615\/CritRevOncog.2013005814","article-title":"Gaucher\"s disease and cancer: a sphingolipid perspective","volume":"18","author":"Barth","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"2024100707200856000_103.3.315.89","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ajo.2004.07.053","article-title":"Fundus abnormalities in a patient with type I Gaucher\"s disease with 12-year follow-up","volume":"139","author":"Wang","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"2024100707200856000_103.3.315.90","first-page":"185","article-title":"Retinal involvement in Gaucher\"s disease","volume":"15","author":"Gonzalez Rodriguez","year":"1992","journal-title":"J Fr Ophtalmol"},{"key":"2024100707200856000_103.3.315.91","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/13816810.2012.716489","article-title":"Analysis of the pre-retinal opacities in Gaucher disease using spectral domain optical coherent tomography","volume":"33","author":"Sheck","year":"2012","journal-title":"Ophthalmic Genet"},{"key":"2024100707200856000_103.3.315.92","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/eye.2013.180","article-title":"Progression of retinal changes in Gaucher disease: a case report","volume":"27","author":"Coussa","year":"2013","journal-title":"Eye"},{"key":"2024100707200856000_103.3.315.93","doi-asserted-by":"crossref","first-page":"340","DOI":"10.5301\/EJO.2010.5797","article-title":"Vitrectomy for vitreous opacities and macular pucker in Gaucher disease","volume":"21","author":"Rapizzi","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"2024100707200856000_103.3.315.94","doi-asserted-by":"crossref","unstructured":"Tantawy AAG , El-Beshlawy A , Marzouk I , et al . Results from a 12-month open-label phase 1\/2 study of velaglucerase alfa in children and adolescents with type 3 Gaucher disease. J Inborn Errors Metab Screen 2018;6 doi:10.1177\/2326409818765564","DOI":"10.1177\/2326409818765564"},{"key":"2024100707200856000_103.3.315.95","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.braindev.2010.02.005","article-title":"A French experience of type 3 Gaucher disease: phenotypic diversity and neurological outcome of 10 patients","volume":"33","author":"Kraoua","year":"2011","journal-title":"Brain Dev"},{"key":"2024100707200856000_103.3.315.96","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000187080.74460.89","article-title":"Saccade testing in the diagnosis and treatment of type 3 Gaucher disease","volume":"65","author":"Pensiero","year":"2005","journal-title":"Neurology"},{"key":"2024100707200856000_103.3.315.97","doi-asserted-by":"publisher","DOI":"10.1007\/s004310000630"},{"key":"2024100707200856000_103.3.315.98","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.112171"},{"key":"2024100707200856000_103.3.315.99","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1005495229655","article-title":"Enzyme replacement therapy in type III Gaucher disease","volume":"22","author":"Tylki-Szyma\u0144ska","year":"1999","journal-title":"J Inherit Metab Dis"},{"key":"2024100707200856000_103.3.315.100","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-008-0873-2"},{"key":"2024100707200856000_103.3.315.101","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-006-0317-9"},{"key":"2024100707200856000_103.3.315.102","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ophtha.2010.10.022","article-title":"Latency vs saccadic parameters in lysosomal trials","volume":"118","author":"Roos","year":"2011","journal-title":"Ophthalmology"},{"key":"2024100707200856000_103.3.315.103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/358534","article-title":"Eye movement impairment recovery in a gaucher patient treated with miglustat","volume":"2010","author":"Accardo","year":"2010","journal-title":"Neurol Res Int"},{"key":"2024100707200856000_103.3.315.104","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13256-016-1147-5","article-title":"Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report","volume":"11","author":"Ceravolo","year":"2017","journal-title":"J Med Case Rep"},{"key":"2024100707200856000_103.3.315.105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbadis.2004.03.007","article-title":"N-octyl-beta-valienamine up-regulates activity of F213I mutant beta-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease","volume":"1689","author":"Lin","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"2024100707200856000_103.3.315.106","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.280016"},{"key":"2024100707200856000_103.3.315.107","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/acn3.292","article-title":"Ambroxol chaperone therapy for neuronopathic Gaucher disease: a pilot study","volume":"3","author":"Narita","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"2024100707200856000_103.3.315.108","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/acn3.33","article-title":"Abnormal pupillary light reflex with chromatic pupillometry in Gaucher disease","volume":"1","author":"Narita","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"2024100707200856000_103.3.315.109","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.24.12.611"},{"key":"2024100707200856000_103.3.315.110","first-page":"55","article-title":"Case report with stress on eye findings","volume":"16","author":"Carbone","year":"1968","journal-title":"Henry Ford Hosp Med J"},{"key":"2024100707200856000_103.3.315.111","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0002-9394(75)90329-3","article-title":"Ocular manifestations of Gaucher\"s disease","volume":"80","author":"Petrohelos","year":"1975","journal-title":"Am J Ophthalmol"},{"key":"2024100707200856000_103.3.315.112","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archopht.122.9.1395","article-title":"Vitreous opacities and retinal vascular abnormalities in Gaucher disease","volume":"122","author":"Shrier","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"2024100707200856000_103.3.315.113","unstructured":"Redslob E , Gery L . Localisations oculaires de la maladie de Gaucher. Ann Ocul 1933;169."},{"key":"2024100707200856000_103.3.315.114","first-page":"p75","article-title":"Electron microscopic study of Gaucher cells in the eye","volume":"24","author":"Ueno","year":"1980","journal-title":"Japanese Journal of Ophthalmology"},{"key":"2024100707200856000_103.3.315.115","doi-asserted-by":"crossref","unstructured":"Abu-Asab MS , Yeung IYL , Ardeljan C . Ocular implications of Gaucher disease. In: Prakash G , Iwata T , eds. Advances in vision research. Tokyo Springer Japan: Genetic Eye Research in Asia and the Pacific, 2017: 413\u201323.","DOI":"10.1007\/978-4-431-56511-6_29"},{"key":"2024100707200856000_103.3.315.116","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-2008-1054908","article-title":"Eye changes in Gaucher\"s disease","volume":"183","author":"Stark","year":"1983","journal-title":"Klin Monbl Augenheilkd"},{"key":"2024100707200856000_103.3.315.117","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-199919060-00019"},{"key":"2024100707200856000_103.3.315.118","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-008-9142-9"},{"key":"2024100707200856000_103.3.315.119","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/13816818409009887","article-title":"The pathology of pingueculae in Gaucher\"s disease","volume":"4","author":"Chu","year":"1984","journal-title":"Ophthalmic Genetics"},{"key":"2024100707200856000_103.3.315.120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1399-0004.1978.tb04242.x","article-title":"Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher\"s disease","volume":"13","author":"Wenger","year":"1978","journal-title":"Clin Genet"},{"key":"2024100707200856000_103.3.315.121","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood.V76.3.646.646","article-title":"Misuse of marrow examination in the diagnosis of Gaucher disease","volume":"76","author":"Beutler","year":"1990","journal-title":"Blood"},{"key":"2024100707200856000_103.3.315.122","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1399-0004.1981.tb00661.x","article-title":"Prenatal diagnosis of Gaucher disease. Assay of the beta-glucosidase activity in amniotic fluid cells cultivated in two laboratories with different cultivation conditions","volume":"19","author":"Svennerholm","year":"1981","journal-title":"Clin Genet"},{"key":"2024100707200856000_103.3.315.123","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-003-1362-0"},{"key":"2024100707200856000_103.3.315.124","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2010.08.012"},{"key":"2024100707200856000_103.3.315.125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2014.02.005"},{"key":"2024100707200856000_103.3.315.126","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/2230-8210.83402","article-title":"Gaucher\"s disease","volume":"15","author":"Bohra","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"2024100707200856000_103.3.315.127","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1750-1172-7-77","article-title":"The French Gaucher\"s disease registry: clinical characteristics, complications and treatment of 562 patients","volume":"7","author":"Stirnemann","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"2024100707200856000_103.3.315.128","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ajmg.a.20117","article-title":"Perinatal-lethal Gaucher disease","volume":"120A","author":"Mignot","year":"2003","journal-title":"Am J Med Genet A"},{"key":"2024100707200856000_103.3.315.129","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2005.04.005"},{"key":"2024100707200856000_103.3.315.130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJM199701303360516","article-title":"Gaucher cells in pulmonary-capillary blood in association with pulmonary hypertension","volume":"336","author":"Ross","year":"1997","journal-title":"N Engl J Med Overseas Ed"},{"key":"2024100707200856000_103.3.315.131","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2005.01.002"},{"key":"2024100707200856000_103.3.315.132","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-7192(02)00122-1"},{"key":"2024100707200856000_103.3.315.133","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.160.6.603"},{"key":"2024100707200856000_103.3.315.134","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21888"},{"key":"2024100707200856000_103.3.315.135","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajh.21684","article-title":"Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types--correlation with genotype and phenotype","volume":"85","author":"Lo","year":"2010","journal-title":"Am J Hematol"},{"key":"2024100707200856000_103.3.315.136","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9070-1"},{"key":"2024100707200856000_103.3.315.137","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1096-8652(200006)64:2<140::AID-AJH14>3.0.CO;2-T","article-title":"Life-threatening splenic hemorrhage in two patients with Gaucher disease","volume":"64","author":"Stone","year":"2000","journal-title":"Am J Hematol"},{"key":"2024100707200856000_103.3.315.138","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-003-1363-z"},{"key":"2024100707200856000_103.3.315.139","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3182057be4"},{"key":"2024100707200856000_103.3.315.140","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00223-014-9923-y","article-title":"Gaucher disease and bone manifestations","volume":"95","author":"Marcucci","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"2024100707200856000_103.3.315.141","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-000-0059-x"},{"key":"2024100707200856000_103.3.315.142","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.75.suppl_1.750002"},{"key":"2024100707200856000_103.3.315.143","doi-asserted-by":"publisher","DOI":"10.1080\/08880010600623232"},{"key":"2024100707200856000_103.3.315.144","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/17474086.2016.1112732","article-title":"Hematological manifestations and complications of Gaucher disease","volume":"9","author":"Linari","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"2024100707200856000_103.3.315.145","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-386862"},{"key":"2024100707200856000_103.3.315.146","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19971128)73:1<41::AID-AJMG9>3.0.CO;2-S"},{"key":"2024100707200856000_103.3.315.147","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03156.x"},{"key":"2024100707200856000_103.3.315.148","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0441-8"},{"key":"2024100707200856000_103.3.315.149","first-page":"129","article-title":"Gaucher\"s disease associated with monoclonal gammapathy of undetermined significance: a case report","volume":"78","author":"Air\u00f2","year":"1993","journal-title":"Haematologica"},{"key":"2024100707200856000_103.3.315.150","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.0954-6820.1975.tb04961.x","article-title":"Gaucher\"s disease and benign monoclonal gammapathy. A case report with immunofluorescence study of bone marrow and spleen","volume":"197","author":"Turesson","year":"1975","journal-title":"Acta Med Scand"},{"key":"2024100707200856000_103.3.315.151","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fneur.2017.00295","article-title":"Saccadic impairments in patients with the norrbottnian form of Gaucher\"s disease type 3","volume":"8","author":"Blume","year":"2017","journal-title":"Front Neurol"},{"key":"2024100707200856000_103.3.315.152","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13023-017-0627-z","article-title":"Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish registry of Gaucher disease","volume":"12","author":"Andrade-Campos","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"2024100707200856000_103.3.315.153","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.pediatrneurol.2014.10.016","article-title":"Oculomotor apraxia in Gaucher disease","volume":"52","author":"Nagappa","year":"2015","journal-title":"Pediatr Neurol"},{"key":"2024100707200856000_103.3.315.154","doi-asserted-by":"publisher","DOI":"10.1177\/0036933013519025"},{"key":"2024100707200856000_103.3.315.155","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s10545-013-9597-z","article-title":"Evoked potentials and neurocognitive functions in pediatric egyptian Gaucher patients on enzyme replacement therapy: a single center experience","volume":"36","author":"Tantawy","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"2024100707200856000_103.3.315.156","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(08)00687-0"},{"key":"2024100707200856000_103.3.315.157","doi-asserted-by":"publisher","DOI":"10.1097\/01.gim.0000196443.42899.25"},{"key":"2024100707200856000_103.3.315.158","doi-asserted-by":"publisher","DOI":"10.1023\/B:BOLI.0000005619.14180.5c"},{"key":"2024100707200856000_103.3.315.159","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.2001.0477"},{"key":"2024100707200856000_103.3.315.160","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2001.3201"},{"key":"2024100707200856000_103.3.315.161","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/mgme.2001.3215","article-title":"Heterologous expression and characterization of a rare Gaucher disease mutation (c.481C > T) from a Canadian aboriginal population using archival tissue samples","volume":"74","author":"Sinclair","year":"2001","journal-title":"Mol Genet Metab"},{"key":"2024100707200856000_103.3.315.162","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.1.261"},{"key":"2024100707200856000_103.3.315.163","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1212\/WNL.55.5.735-g","article-title":"Gaucher disease with oculomotor apraxia and cardiovascular calcification","volume":"55","author":"Uyama","year":"2000","journal-title":"Neurology"},{"key":"2024100707200856000_103.3.315.164","first-page":"52","article-title":"Oculomotor apraxia in a case of Gaucher\"s disease with homozygous T1448C mutation","volume":"37","author":"Tsai","year":"1996","journal-title":"Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi"},{"key":"2024100707200856000_103.3.315.165","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.2.151"},{"key":"2024100707200856000_103.3.315.166","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2007-979754","article-title":"Enzyme infusion therapy of the norrbottnian (type 3) Gaucher disease","volume":"26","author":"Erikson","year":"1995","journal-title":"Neuropediatrics"},{"key":"2024100707200856000_103.3.315.167","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(95)91975-9","article-title":"1342C mutation in Gaucher\"s disease","volume":"346","author":"Beutler","year":"1995","journal-title":"The Lancet"},{"key":"2024100707200856000_103.3.315.168","first-page":"212","article-title":"Gaucher disease: molecular heterogeneity and phenotype-genotype correlations","volume":"45","author":"Theophilus","year":"1989","journal-title":"Am J Hum Genet"},{"key":"2024100707200856000_103.3.315.169","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0887-8994(89)90042-8","article-title":"Oculomotor apraxia: the presenting sign of Gaucher disease","volume":"5","author":"Gross-Tsur","year":"1989","journal-title":"Pediatr Neurol"},{"key":"2024100707200856000_103.3.315.170","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1981.03930020676010"},{"key":"2024100707200856000_103.3.315.171","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1212\/WNL.30.2.152","article-title":"Electroencephalographic findings in Gaucher disease","volume":"30","author":"Nishimura","year":"1980","journal-title":"Neurology"},{"key":"2024100707200856000_103.3.315.172","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1980.00500510050008"},{"key":"2024100707200856000_103.3.315.173","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/jhg.2016.158","article-title":"Norrbottnian clinical variant of Gaucher disease in Southern Italy","volume":"62","author":"Sestito","year":"2017","journal-title":"J Hum Genet"},{"key":"2024100707200856000_103.3.315.174","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bcmd.2014.05.007","article-title":"Outcome of early-treated type III Gaucher disease patients","volume":"53","author":"Lee","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"2024100707200856000_103.3.315.175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0028-3886.111136","article-title":"Horizontal gaze palsy with progressive myoclonic epilepsy: rare presentation of Gaucher\"s disease","volume":"61","author":"Sharma","year":"2013","journal-title":"Neurol India"},{"key":"2024100707200856000_103.3.315.176","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4318\/tjg.2011.0244","article-title":"Pediatric Gaucher experience in South Marmara region of Turkey","volume":"22","author":"Erdem\u0131r","year":"2011","journal-title":"Turk J Gastroenterol"},{"key":"2024100707200856000_103.3.315.177","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-008-0832-y"},{"key":"2024100707200856000_103.3.315.178","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0577-z"},{"key":"2024100707200856000_103.3.315.179","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1353-8020(02)00096-2","article-title":"Adult-onset neuronopathic form of Gaucher\"s disease: a case report","volume":"9","author":"Guimar\u00e3es","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"2024100707200856000_103.3.315.180","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420412"},{"key":"2024100707200856000_103.3.315.181","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-0404.1992.tb05109.x","article-title":"Hydrocephalus, corneal opacities, deafness, valvular heart disease, deformed toes and leptomeningeal fibrous thickening in adult siblings: a new syndrome associated with beta-glucocerebrosidase deficiency and a mosaic population of storage cells","volume":"86","author":"Uyama","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"2024100707200856000_103.3.315.182","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1755-3768.1985.tb01537.x","article-title":"Gaucher disease - Norrbottnian type ocular abnormalities","volume":"63","author":"Erikson","year":"1985","journal-title":"Acta Ophthalmol"},{"key":"2024100707200856000_103.3.315.183","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1212\/WNL.33.8.994","article-title":"Non-infantile neuronopathic Gaucher\"s disease: a clinicopathologic study","volume":"33","author":"Winkelman","year":"1983","journal-title":"Neurology"},{"key":"2024100707200856000_103.3.315.184","first-page":"p98","article-title":"Clinical and histopathological studies of a case with juvenile form of Gaucher\u2032 s disease","volume":"21","author":"Ueno","year":"1977","journal-title":"Jpn J Ophthalmol"},{"key":"2024100707200856000_103.3.315.185","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.40.5.470"},{"key":"2024100707200856000_103.3.315.186","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.38.9.849"},{"key":"2024100707200856000_103.3.315.187","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-78-6-883"},{"key":"2024100707200856000_103.3.315.188","first-page":"423","article-title":"Ocular findings associated with meningomyelocele in two brothers with Gaucher\"s disease","volume":"14","author":"Yaghoubi","year":"2009","journal-title":"Bina Journal of Ophthalmology"},{"key":"2024100707200856000_103.3.315.189","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.85.12.1477"},{"key":"2024100707200856000_103.3.315.190","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2005.04.005"},{"key":"2024100707200856000_103.3.315.191","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0248-8663(03)00267-4","article-title":"Gaucher\"s disease in Tunisia (multicenter study)","volume":"25","author":"Chaabouni","year":"2004","journal-title":"Rev Med Interne"},{"key":"2024100707200856000_103.3.315.192","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0140-6736(94)90462-6","article-title":"Enzyme replacement treatment in type 1 and type 3 Gaucher\"s disease","volume":"344","author":"Bembi","year":"1994","journal-title":"The Lancet"},{"key":"2024100707200856000_103.3.315.193","first-page":"497","article-title":"Macular degenerescence of a special type in a case of Gaucher\"s disease","volume":"6","author":"Collier","year":"1961","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"2024100707200856000_103.3.315.194","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jamaophthalmol.2017.5208","article-title":"Retinal deposits in a young woman","volume":"136","author":"Oliver","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"2024100707200856000_103.3.315.195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/01658109309038144","article-title":"Oculomotor signs in infantile Gaucher disease","volume":"13","author":"Vivian","year":"1993","journal-title":"Neuroophthalmology"},{"key":"2024100707200856000_103.3.315.196","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230315"},{"key":"2024100707200856000_103.3.315.197","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1651-2227.1962.tb06522.x","article-title":"Neurological signs in a juvenile form of Gaucher\"s disease","volume":"51","author":"Herrlin","year":"1962","journal-title":"Acta Paediatr"},{"key":"2024100707200856000_103.3.315.198","doi-asserted-by":"crossref","first-page":"297","DOI":"10.17533\/udea.iatreia.v30n3a05","article-title":"Ocular manifestations of Gaucher disease: case report and literature review","volume":"30","author":"Mej\u00eda-Turizo","year":"2017","journal-title":"Iatreia"},{"key":"2024100707200856000_103.3.315.199","doi-asserted-by":"publisher","DOI":"10.1177\/08830738050200020801"},{"key":"2024100707200856000_103.3.315.200","first-page":"517","article-title":"Gaucher\"s disease","volume":"5","author":"Bloem","year":"1936","journal-title":"QJM: An International Journal of Medicine"},{"key":"2024100707200856000_103.3.315.201","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1097\/ICO.0b013e31828d6d81","article-title":"Corneal manifestations and in vivo confocal microscopy of Gaucher disease","volume":"32","author":"Geens","year":"2013","journal-title":"Cornea"},{"key":"2024100707200856000_103.3.315.202","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1002\/clc.20348","article-title":"Gaucher disease with communicating hydrocephalus and cardiac involvement","volume":"33","author":"Cindik","year":"2010","journal-title":"Clin Cardiol"},{"key":"2024100707200856000_103.3.315.203","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1034\/j.1399-0004.2001.590511.x","article-title":"Severe valvular and aortic arch calcification in a patient with Gaucher\"s disease homozygous for the D409H mutation","volume":"59","author":"George","year":"2001","journal-title":"Clin Genet"},{"key":"2024100707200856000_103.3.315.204","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.109789"},{"key":"2024100707200856000_103.3.315.205","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0002-9394(98)00249-9","article-title":"Corneal opacities in Gaucher disease","volume":"126","author":"Guemes","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"2024100707200856000_103.3.315.206","first-page":"211","article-title":"Hydrocephalus, corneal opacities, deafness, left ventricle hypertrophy, clinodactyly in an adolescent patient. A new syndrome associated with glucocerebrosidase deficiency","volume":"6","author":"Erduran","year":"1995","journal-title":"Genet Couns"},{"key":"2024100707200856000_103.3.315.207","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/112067219500500201","article-title":"Morphological and biochemical assessment of the cornea in a Gaucher disease carrier with keratoconus","volume":"5","author":"Salgado-Borges","year":"1995","journal-title":"Eur J Ophthalmol"},{"key":"2024100707200856000_103.3.315.208","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000309588","article-title":"New ocular findings in Gaucher\"s disease: a report of two brothers","volume":"191","author":"Sasaki","year":"1985","journal-title":"Ophthalmologica"},{"key":"2024100707200856000_103.3.315.209","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/09273949309086547","article-title":"Chronic uveitis in Gaucher\"s disease","volume":"1","author":"Raz","year":"1993","journal-title":"Ocul Immunol Inflamm"},{"key":"2024100707200856000_103.3.315.210","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamaophthalmol.2013.7817","article-title":"Preretinal and posterior vitreous deposits in Gaucher disease","volume":"132","author":"Hsing","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"2024100707200856000_103.3.315.211","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jchromb.2004.02.027","article-title":"Evaluation of sphingolipids in vitreous bodies from a patient with Gaucher disease, using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry","volume":"806","author":"Fujiwaki","year":"2004","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2024100707200856000_103.3.315.212","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1055\/s-2008-1035003","article-title":"Uveitis masquerade syndrome in Gaucher disease. Causal treatment by alglucerase substitution therapy","volume":"213","author":"Dann","year":"1998","journal-title":"Klin Monbl Augenheilkd"},{"key":"2024100707200856000_103.3.315.213","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/01658107.2017.1420084","article-title":"Photo essay: retinal changes in type 3 Gaucher disease","volume":"42","author":"Anand","year":"2018","journal-title":"Neuroophthalmology"},{"key":"2024100707200856000_103.3.315.214","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5935\/0034-7280.20170066","article-title":"Ophthalmologic fndings in Gaucher\u2019s disease type III: case report","volume":"76","author":"Matos","year":"2017","journal-title":"Rev Bras Oftalmol"},{"key":"2024100707200856000_103.3.315.215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3109\/03009734.2016.1158756","article-title":"The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy","volume":"121","author":"Sawicka-Gutaj","year":"2016","journal-title":"Ups J Med Sci"},{"key":"2024100707200856000_103.3.315.216","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13816810.2016.1193878","article-title":"A case of traction retinal detachment in a patient with Gaucher disease","volume":"38","author":"Watanabe","year":"2017","journal-title":"Ophthalmic Genet"},{"key":"2024100707200856000_103.3.315.217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1651-2227.1986.tb14936.x","article-title":"Gaucher disease\u2013norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment","volume":"326","author":"Erikson","year":"1986","journal-title":"Acta Paediatr Scand Suppl"},{"key":"2024100707200856000_103.3.315.218","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1980.01020041054010"},{"key":"2024100707200856000_103.3.315.219","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00006982-200006000-00021","article-title":"Gaucher\u02bcs disease associated with choroidal neovascularization","volume":"20","author":"Giovannini","year":"2000","journal-title":"Retina"},{"key":"2024100707200856000_103.3.315.220","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.7.3.200"},{"key":"2024100707200856000_103.3.315.221","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ymgme.2013.04.001","article-title":"Retinal thinning in Gaucher disease patients and carriers: results of a pilot study","volume":"109","author":"McNeill","year":"2013","journal-title":"Mol Genet Metab"},{"key":"2024100707200856000_103.3.315.222","first-page":"38","article-title":"Augenhintergrund bei der kindlichen gaucherschen erkrankung","volume":"64","author":"Eyb","year":"1952","journal-title":"Wien Klin Wochenschr"},{"key":"2024100707200856000_103.3.315.223","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20000701-13","article-title":"Macular changes in type I Gaucher\"s disease","volume":"31","author":"Rosenthal","year":"2000","journal-title":"Ophthalmic Surg Lasers"},{"key":"2024100707200856000_103.3.315.224","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1964.00970010505009"},{"key":"2024100707200856000_103.3.315.225","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.48.2.172"},{"key":"2024100707200856000_103.3.315.226","first-page":"461","article-title":"A case of Gaucher\"s disease associated with peripheral retinal ischemia","volume":"12","author":"Jaime","year":"1989","journal-title":"J Fr Ophtalmol"},{"key":"2024100707200856000_103.3.315.227","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1988.01060140515012"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2018-312846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T18:42:02Z","timestamp":1728326522000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2018-312846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,5]]},"references-count":227,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,2,21]]},"published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1136\/bjophthalmol-2018-312846"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312846","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,5]]}}}